CASP3 and prostate cancer: Caspases 3, p53, and NF-κB are potential therapeutic targets for various types of cancers, including breast cancer, lung cancer, leukemia, lymphoma, colon cancer, ovarian cancer, prostate cancer, and hematologic malignancies like leukemia, lymphoma, and multiple myeloma [9–14].